Anti-Infective Agents Market Size - Global Industry, Share, Analysis, Trends and Forecast 2022 - 2030
The Global Anti-Infective Agents Market Size accounted for USD 122.1 Billion in 2021 and is estimated to achieve a market size of USD 161.6 Billion by 2030 growing at a CAGR of 3.6% from 2022 to 2030. Extensive research and development activities in the creation of novel medications with excellent potential and efficiency against multi-drug microbial resistance are one of the primary causes driving the anti-infective agents market growth. Furthermore, new antibacterial and antifungal drug developments are expected to boost the anti-infective agents market value over the projection period.
Anti-Infective Agents Market Report Key Highlights
- Global anti-infective agents market revenue is expected to increase by USD 161.6 Billion by 2030, with a 3.6% CAGR from 2022 to 2030
- North America region led with more than 28% of anti-infective agents market share in 2021
- Asia-Pacific anti-infective agents market growth will observe strongest CAGR from 2022 to 2030
- By type, the antiviral segment has accounted market share of over 48% in 2021
- By distribution channel, hospital pharmacies segment engaged more than 32% of the total market share in 2021
- Increasing prevalence of contagious diseases, fuels the anti-infective agents market size
An anti-infective agent is a medication that can prevent or stop the growth of an infectious organism. Anti-infective agents also can completely destroy the infectious organism. Antifungals, anthelmintics, antimalarials, anthelmintics, antituberculosis drugs, antivirals, as well as antiprotozoals comprise the anti-infective class.
Global Anti-Infective Agents Market Trends
Market Drivers
- Increasing global geriatric population
- Growing incidence of target diseases including respiratory viruses, STIs, and hospital-acquired infections
- Rising efforts to raise awareness of contagious diseases
Market Restraints
- Advancement of multidrug-resistant organisms
- High R&D costs
Market Opportunities
- Rising investments in anti-infective drug research and development
- Increasing the number of drugs approved for the treatment
Anti-Infective Agents Market Report Coverage
| Market | Anti-Infective Agents Market |
| Anti-Infective Agents Market Size 2021 | USD 122.1 Billion |
| Anti-Infective Agents Market Forecast 2030 | USD 161.6 Billion |
| Anti-Infective Agents Market CAGR During 2022 - 2030 | 3.6% |
| Anti-Infective Agents Market Analysis Period | 2018 - 2030 |
| Anti-Infective Agents Market Base Year | 2021 |
| Anti-Infective Agents Market Forecast Data | 2022 - 2030 |
| Segments Covered | By Type, By Route of Administration, By Distribution Channel, And By Geography |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
| Key Companies Profiled | Abbott Laboratories, Astellas Pharma Inc., Bayer AG, Bristol-Myers Squibb Company, Gilead Sciences, Inc., GlaxoSmithKline plc., Johnson & Johnson Services, Inc., Merck & Co., Inc., Novartis AG, Pfizer, Inc., and Sanofi. |
| Report Coverage |
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis |
The rising predominance of irresistible illnesses, for example, HIV, H1N1, and Ebola infection mirror the significant changes in the standards of conduct of networks over the ongoing decades. The societal changes and expanding mindfulness among medicinal services experts and patients are driving the growth. Broad R&D endeavors relating to the advancement of new medications with high viability and intensity against multi-sedate safe miniaturized scale living beings are one of the main considerations invigorating the growth.
For example, in 2016, the Food and Drug Administration (FDA) affirmed drugs, for example, Discovery by Gilead, for the treatment of HIV-1 contamination and Zephier by Merck that objectives constant Hepatitis C infection (HCV) genotypes 1 or 4 diseases in grown-ups.
Associations, for example, the World Health Organization (WHO) and Centers for Disease Control and Prevention (CDC) are effectively engaged in spreading mindfulness among individuals in regard to the lethal ramifications of irresistible illnesses and the significance of early treatment. The CDC has teamed up with the National Health Ministry (NHM) to try to spread mindfulness and to upgrade the treatment of transferable illnesses in creating nations, for example, Brazil, China, Nigeria, and India.
Nevertheless, the presentation of novel therapeutics with expanded strength and viability and the commercialization of pipeline items, for example, the commercialization of Omadacycline in 2018 for the treatment of Community-Acquired Bacterial Pneumonia (CABP), are required to drive the growth of the anti-infective agents market. Most organizations are growing their item portfolios by concentrating on undiscovered chances. For example, Gilead propelled Sovaldi, the main ever oral prescription for the treatment of HCV genotype 2 and 3 in 2013.
Anti-Infective Agents Market Segmentation
The global anti-infective agents market segmentation is based on type, route of administration, distribution channel, and geography.
Anti-Infective Agents Market By Type
- Antibacterials
- Cephalosporins
- Fluoroquinolones
- Penicillin
- Carbapenem
- Macrolides
- Others
- Antivirals
- Echinocandins
- Azoles
- Polyenes
- Others
- Antifungals
According to an anti-infective agents industry analysis, antivirals are expected to account for the majority of the market in 2021, owing to the high cost of new intensive anti-viral treatments such as Vicriviroc for the treatment of HIV. The antibacterial portion is anticipated to enroll the quickest CAGR during the conjecture time frame, as antibacterial is the principal line of treatment for a vast scope of diseases. Expanded medicine and the availability of antibacterial due to their over-the-counter status are anticipated to additionally drive the fragment.
The advancement of blended medications to treat and forestall genuine and hazardous diseases is relied upon to push the utilization of anti-infective medications. For example, in 2012, Gilead Sciences, Inc. propelled Stribild, a far-reaching treatment routine comprehensive of four medications (cobicistat, elvitegravir, emtricitabine, and tenofovirdisoproxilfumarate) utilized for the treatment of HIV patients without earlier retroviral treatment record.
Anti-Infective Agents Market By Route of Administration
- Topical
- IV
- Oral
- Others
In terms of the route of administration, the oral course of the organization was assessed to be the biggest portion in 2021 attributable to new item improvement and the nearness of a solid item pipeline. Medical clinic drug stores drove the anti-infective agents market in 2021 while the web-based business is relied upon to be the quickest developing fragment during the figure time frame. Viable illness the executives includes a scope of long haul methodologies, for example, new item advancement, mergers and acquisitions, co-improvement, and business extensions. For example, in 2015, ReViral got financing of USD 21 million for the improvement of its RV521 sedate from the Wellcome Trust.
Anti-Infective Agents Market By Distribution Channel
- Hospital Pharmacies
- E-Commerce
- Specialty Pharmacies
- Retail Pharmacies
- Others
According to the anti-infective agents market forecast, the E-commerce category was predicted to develop at an exponential rate over the projected period. When relative to other distribution channels, this growth is due to convenience, adaptability, and simplicity. Various reasons, such as ease of purchase and improved healthcare facilities in developing nations, are projected to boost expansion.
Anti-Infective Agents Market Regional Outlook
North America
- U.S.
- Canada
Europe
- U.K.
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- India
- Japan
- China
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
The Middle East & Africa
- South Africa
- GCC Countries
- Rest of the Middle East & Africa (ME&A)
North America Dominates The Global Anti-Infective Agents Market
The North America market was one of the main local markets regarding income in 2021. The high pervasiveness of irresistible maladies incorporating clinic-obtained contaminations in both, kids and grown-ups, and the resultant abuse of antibiotics combined with the expanded availability of non-solution anti-infectives are the real drivers. The Asia-Pacific is one of the quickest developing territorial markets attributable to the nearness of high, neglected interest for novel medications, fast upgrades in medicinal services foundation combined with bringing issues to light among social insurance experts and patients.
Anti-Infective Agents Market Players
Some of the top anti-infective agents market companies offered in the professional report include Abbott Laboratories, Astellas Pharma Inc., Bayer AG, Bristol-Myers Squibb Company, Gilead Sciences, Inc., GlaxoSmithKline plc., Johnson & Johnson Services, Inc., Merck & Co., Inc., Novartis AG, Pfizer, Inc., and Sanofi.
Frequently Asked Questions
What is the size of global anti-infective agents market in 2021?
The estimated value of global anti-infective agents market in 2021 was accounted to be USD 122.1 Billion.
What is the CAGR of global anti-infective agents market during forecast period of 2022 to 2030?
The projected CAGR anti-infective agents market during the analysis period of 2022 to 2030 is 3.6%.
Which are the key players operating in the market?
The prominent players of the global anti-infective agents market are Abbott Laboratories, Astellas Pharma Inc., Bayer AG, Bristol-Myers Squibb Company, Gilead Sciences, Inc., GlaxoSmithKline plc., Johnson & Johnson Services, Inc., Merck & Co., Inc., Novartis AG, Pfizer, Inc., and Sanofi.
Which region held the dominating position in the global anti-infective agents market?
North America held the dominating anti-infective agents market during the analysis period of 2022 to 2030.
Which region registered the fastest growing CAGR for the forecast period of 2022 to 2030?
Asia-Pacific region exhibited fastest growing CAGR for anti-infective agents market during the analysis period of 2022 to 2030.
What are the current trends and dynamics in the global anti-infective agents market?
Growing incidence of target diseases including respiratory viruses, STIs, and hospital-acquired infections the globe drives the growth of global anti-infective agents market.
By distribution channel segment, which sub-segment held the maximum share?
Based on distribution channel, hospital pharmacies segment is expected to hold the maximum share of the anti-infective agents market.
Select Licence Type
Connect with our sales team
Why Acumen Research And Consulting
100%
Customer Satisfaction
24x7
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
